Brochure
5 May 2026
ORAL HEALTH BY BLIS
PDF 1.1 MB
The category case for oral probiotics, the oral-systemic health story, full strain profiles for BLIS M18™ (dental, gum, plaque) and BLIS K12™ (ENT, throat, fresh breath), a curated selection of clinical evidence for each strain, and information on application areas and what BLIS provides to formulators.
Content provided by our supplier
BLIS Technologies Ltd
-
Country/Region:New Zealand
-
On CPHI since:2024
-
Certificates:2
-
Employees:25 - 49
Company types
Primary activities
Other Content from BLIS Technologies Ltd (2)
-
News BLIS Technologies Enters the Pet Health Category with Clinically-Studied Oral Probiotics for Dogs
BLIS K12™ and BLIS M18™ — the world's first commercialised oral probiotic strains — extend their 25-year human health heritage into companion animal care, addressing one of the most prevalent yet under-treated conditions in dogs.
-
Video PROBIOTICS MADE TO MATTER | BLIS TECHNOLOGIES
BLIS Technologies are the masters of the oral microbiome. We are dedicated to discovering, developing, and supplying clinically validated probiotic strains that support oral and upper respiratory health. We were the first to discover Streptococcus salivarius probiotics — BLIS K12™ and BLIS M18™ — and we’ve been leading the science of the oral cavity ever since. BLIS K12™ and BLIS M18™ are backed by decades of research, strong IP, and extensive clinical validation.